[PLX] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
07-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -37.63%
YoY- -35.91%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 12,247 10,439 27,018 663 2,006 4,553 2,469 191.70%
PBT -7,743 -7,264 9,781 -15,544 -11,294 -9,400 -15,141 -36.12%
Tax 3 190 99 230 75 132 916 -97.81%
NP -7,743 -7,264 9,781 -15,544 -11,294 -9,400 -15,141 -36.12%
Tax Rate - - -1.01% - - - - -
Total Cost 19,990 17,703 17,237 16,207 13,300 13,953 17,610 8.84%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -63.22 -69.59 36.20 -2,344.49 -563.01 -206.46 -613.24 -78.10%
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.52 -0.49 0.66 -1.05 -0.77 -0.65 -1.08 -38.65%
EPS Diluted -0.52 -0.49 0.66 -1.05 -0.77 -0.65 -1.04 -37.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.